Soc. for Research on Nicotine & Tobacco Annual Meeting

尼古丁和烟草研究学会（SRNT）成立于1994年，旨在解决与尼古丁和烟草的许多直接影响、烟草制品在我们社会中的使用以及烟草依赖的预防和治疗相关的研究的协调科学论述的需求。它仍然是唯一一个主要致力于促进尼古丁和烟草研究并传播研究结果的国家组织。SRNT是一个多学科组织，其成员的兴趣范围从神经科学到临床和预防干预到烟草政策。SRNT将于2003年2月在新奥尔良喜来登酒店举行第九次年会。我们要求NIDA通过会议赠款机制为这次会议和随后的四次年会提供部分支持，NCI和CDC是次要资助者。在年会上，一个由多学科科学家组成的小组，其中许多人由NIDA，NCI和其他NIH研究所资助，将举办讲座，海报，研讨会和其他会议，突出尼古丁和烟草的最新研究。这项研究将涵盖尼古丁和烟草对公共健康影响的最广泛范围，包括神经科学、临床药理学、治疗、预防、流行病学和卫生政策。三位杰出研究人员的主题演讲将突出三个普遍感兴趣的领域的发展：基础研究，临床和公共卫生/流行病学。新研究人员的工作将通过特别口头会议和奖励计划得到强调。此外，就在2003年年会之前，我们计划举行一次为期一天的关于尼古丁和烟草研究全球合作的专题会议（尽管这里不要求对该会议提供支持）。总的来说，SRNT年会通过提供一个论坛来传播和讨论尼古丁和烟草研究的最新发现以及跨研究领域交流思想的机会，发挥了宝贵的作用。NIDA、NCI和CDC对会议的部分支持将进一步突出这些机构对尼古丁和烟草研究重要性的承诺。

DESCRIPTION (provided by applicant): The Society for Research on Nicotine and Tobacco (SRNT) was founded in 1994 to address the need for coordinated scientific discourse on research related to the many direct effects of nicotine and tobacco, the use of tobacco products in our society, and the prevention and treatment of tobacco dependence. It is still the only national organization primarily devoted to promoting the conduct of research on nicotine and tobacco and disseminating findings from this research. SRNT is a multidisciplinary organization including members whose interests range from neuroscience to clinical and prevention interventions to tobacco policy. SRNT will hold its ninth annual meeting in February 2003 at the Sheraton New Orleans Hotel. We are requesting partial support for this and four subsequent annual meetings from NIDA, with NCI and CDC as secondary funders, through the conference grant mechanism. At the annual meetings, a multidisciplinary group of scientists, many of whom are funded by NIDA, NCI, and other NIH institutes, will present talks, posters, symposia, and other sessions that highlight the latest research on nicotine and tobacco. This research will cover the broadest possible scope of the influence of nicotine and tobacco on public health, including neuroscience, clinical pharmacology, treatment, prevention, epidemiology, and health policy. Theme lectures by three distinguished researchers will highlight developments in the three general interest areas: basic research, clinical, and public health/epidemiology. The work of new investigators will be highlighted via special oral sessions and awards programs. In addition, just prior to the 2003 annual meeting, we plan to hold a 1-day special topics meeting on global collaborations in nicotine and tobacco research (although support for that meeting is not being requested here). Overall, the SRNT annual meeting serves a valuable function by providing a forum for dissemination and discussion of the latest findings in nicotine and tobacco research and the opportunity for cross-fertilization of ideas across research areas. Partial support of the meeting by NIDA, NCI, and CDC would further highlight these agencies' commitment to the importance of nicotine and tobacco research.